Marker Therapeutics, Inc. (MRKR)
0.9466
-0.06
(-6.28%)
USD |
NASDAQ |
Oct 13, 16:00
0.9466
0.00 (0.00%)
After-Hours: 19:01
Marker Therapeutics Total Liabilities (Quarterly) : 2.42M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.42M |
| March 31, 2026 | 3.638M |
| December 31, 2025 | 2.274M |
| September 30, 2025 | 3.346M |
| June 30, 2025 | 4.278M |
| March 31, 2025 | 2.501M |
| December 31, 2024 | 3.464M |
| September 30, 2024 | 3.461M |
| June 30, 2024 | 1.972M |
| March 31, 2024 | 2.304M |
| December 31, 2023 | 3.075M |
| September 30, 2023 | 2.780M |
| June 30, 2023 | 2.921M |
| March 31, 2023 | 12.03M |
| December 31, 2022 | 14.82M |
| September 30, 2022 | 18.51M |
| June 30, 2022 | 24.29M |
| March 31, 2022 | 19.25M |
| December 31, 2021 | 24.15M |
| September 30, 2021 | 19.66M |
| June 30, 2021 | 17.23M |
| March 31, 2021 | 15.87M |
| December 31, 2020 | 18.27M |
| September 30, 2020 | 17.97M |
| June 30, 2020 | 14.01M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.390M |
| December 31, 2019 | 2.273M |
| September 30, 2019 | 3.521M |
| June 30, 2019 | 3.591M |
| March 31, 2019 | 3.377M |
| December 31, 2018 | 2.804M |
| September 30, 2018 | 3.701M |
| June 30, 2018 | 3.747M |
| March 31, 2018 | 2.314M |
| December 31, 2017 | 1.522M |
| September 30, 2017 | 1.768M |
| June 30, 2017 | 1.576M |
| March 31, 2017 | 1.964M |
| December 31, 2016 | 1.737M |
| September 30, 2016 | 2.204M |
| June 30, 2016 | 23.12M |
| March 31, 2016 | 31.46M |
| December 31, 2015 | 28.01M |
| September 30, 2015 | 8.847M |
| June 30, 2015 | 13.06M |
| March 31, 2015 | 3.302M |
| December 31, 2014 | 1.248M |
| September 30, 2014 | 1.300M |
| June 30, 2014 | 2.598M |
| March 31, 2014 | 5.615M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.59M |
| Shareholders Equity (Quarterly) | 12.17M |
| Current Ratio | 6.027 |